Insight Molecular Diagnostics (IMDX) Asset Writedowns and Impairment (2020 - 2024)
Insight Molecular Diagnostics (IMDX) posted Asset Writedowns and Impairment of $36.9 million for Q4 2024, up 922600.0% sequentially from -$4000.0 in Q4 2023, and up 922600.0% YoY from N/an in Q1 2024.
Insight Molecular Diagnostics (IMDX) Asset Writedowns and Impairment (2020 - 2024) Analysis & Trends
Insight Molecular Diagnostics (IMDX) has 3 years of Asset Writedowns and Impairment data on file, last reported at $36.9 million in Q4 2024.
- Quarterly Asset Writedowns and Impairment rose 922600.0% year-over-year to $36.9 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $38.7 million (up 472.1% YoY) and the FY2025 annual result came in at $14.6 million, down 65.16% from the prior year.
- Asset Writedowns and Impairment grew to $36.9 million in Q4 2024 per IMDX's latest filing, from -$4000.0 in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $36.9 million in Q4 2024, with the low at -$334000.0 in Q3 2020.
- Average Asset Writedowns and Impairment over 3 years is $5.5 million, with a median of $333500.0 recorded in 2020.
- The widest YoY moves for Asset Writedowns and Impairment: up 922600.0% in 2024, down 922600.0% in 2024.
- Insight Molecular Diagnostics' Asset Writedowns and Impairment stood at $334000.0 in 2020, then slumped by 101.2% to -$4000.0 in 2023, then jumped by 922600.0% to $36.9 million in 2024.
- Business Quant data shows IMDX's Asset Writedowns and Impairment at $36.9 million in Q4 2024, -$4000.0 in Q4 2023, and $1.8 million in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn |
| 10 | Insight Molecular Diagnostics | 196.41 Mn | 167.48 Mn | 15,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 36.90 Mn |
| Dec 31, 2024 | 36.90 Mn |
| Dec 31, 2023 | -4,000.00 |
| Dec 31, 2023 | -4,000.00 |
| Sep 30, 2023 | 1.81 Mn |
| Sep 30, 2023 | 1.81 Mn |
| Jun 30, 2023 | -50,000.00 |
| Jun 30, 2023 | -50,000.00 |
| Mar 31, 2023 | 5.00 Mn |
| Mar 31, 2023 | 5.00 Mn |
| Dec 31, 2020 | 334,000.00 |
| Dec 31, 2020 | 334,000.00 |
| Sep 30, 2020 | -334,000.00 |
| Sep 30, 2020 | -334,000.00 |
| Jun 30, 2020 | 333,000.00 |
| Jun 30, 2020 | 333,000.00 |